Molagri Inc.

Based in Canada, Molagri Inc. , operates as a biotechnology company developing targeted biological pesticides for crop protection. Based in Toronto, Canada and founded in 2026, Molagri Inc. is focused on agricultural biotechnology.

The company specializes in developing precision biopesticides to combat pest resistance. In September 2026, Molagri Inc. raised USD 1 mn in Unspecified Round funding from Y Combinator and Julian Capital. Molagri specializes in the development of precisely engineered biopesticides designed to address the increasing challenges in crop protection, specifically targeting insect pests with minimal environmental impact and cost.

Their core product offering centers around Virus-Like Particles (VLPs), which are genetically engineered to deliver specific instructions to the cells of targeted pests, leading to the production of a species-specific toxin that eliminates the pest. This innovative technology is tailored for scalable manufacturing and real-world agricultural applications, focusing on a modular approach that allows the adaptation of solutions to various insect species without the need for extensive redesigns as agricultural challenges evolve. The primary customers and end users of these solutions include farmers and agricultural producers seeking effective pest management tools. Molagri's products are positioned for commercial availability in North America and possibly other regions with a demand for advanced agricultural biologicals.

Molagri's revenue model is built around direct partnerships and sales within the agricultural sector, focusing on delivering innovative pest management solutions to growers. The company establishes relationships with farming cooperatives, distributors, and agricultural service providers, enabling a B2B transaction structure that facilitates the deployment of their biopesticides at scale. Pricing strategies may involve tiered subscription models or purchase agreements for larger quantities of their flagship biopesticide products, promoting accessibility for various sizes of agricultural operations. These transactions are designed to meet the needs of growers facing challenges from resistance and changing regulations in pest management.

The company’s approach aims to create a sustainable revenue stream while delivering ecological benefits to the farming industry. The company will use the funding to support its efforts to develop and advance precision biopesticides and pest-control solutions that adapt to evolving resistance threats.